Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. News
  7. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
Delayed Quote. Delayed NSE India Stock Exchange - 01/21 07:09:12 am
808.75 INR   -1.37%
06:14aSUN PHARMACEUTICAL INDUSTRIES : Loss of Share Certificates
PU
01/19Sun Pharma to announce third quarter results on January 31, 2022
AQ
01/13Indian Benchmarks Extend Gains on Thursday; Tata Steel Jumps 6%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Indian shares slip as Sun Pharma drags ahead of earnings

11/02/2021 | 12:39am EST

BENGALURU, Nov 2 (Reuters) - Indian shares reversed course to fall slightly on Tuesday as pharmaceutical stocks lost their footing on the back of a slide in heavyweight Sun Pharma ahead of its quarterly earnings results later in the day.

By 0506 GMT, the blue chip NSE Nifty 50 index fell 0.15% to 17,902.25, while the benchmark S&P BSE Sensex was down 0.25% at 59,989.43.

"Typically, (the festive season of) Diwali week sees lower volume with a lot of traders on holiday... we normally don't see a big sell-off," said Deepak Jasani, head of retail research at HDFC Securities.

The Nifty and Sensex had shed 3.3% each over the final three sessions last week on concerns of overvaluations and heavy foreign selling, before recouping some of those losses on Monday with gains of more than 1%.

On Tuesday, the Nifty Pharma Index fell 0.69%, snapping two straight sessions of losses, as Sun Pharma slipped 2.3% to be the biggest loser on the Nifty 50. The company is due to report September-quarter earnings later in the day.

Limiting losses, however, was the Nifty Auto Index gaining 1.41%. Shares of Tata Motors rose as much as 5% after the carmaker projected pre-tax earnings margin and free cash flow at its Jaguar Land Rover unit to turn positive in the second half of fiscal 2022.

The Nifty Realty Index rose 2.86%, extending gains for a third session.

Among other stocks, agrochemical holding company PI Industries shed 7.6% after its deal with active pharmaceutical ingredient maker IND Swift Laboratories fell through.

Joining a long list of Indian startups that have tapped the capital market this year, logistics firm Delhivery Ltd filed for an initial public offering of up to 74.6 billion rupees.

($1 = 74.8050 Indian rupees) (Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Ramakrishnan M.)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
IND-SWIFT LABORATORIES LIMITED -2.60% 80.65 End-of-day quote.18.43%
PI INDUSTRIES LIMITED -3.22% 2594.1 End-of-day quote.-14.50%
SUN PHARMACEUTICAL INDUSTRIES LTD. -1.37% 808.75 Delayed Quote.-4.37%
TATA MOTORS LIMITED -2.66% 502 End-of-day quote.4.07%
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
06:14aSUN PHARMACEUTICAL INDUSTRIES : Loss of Share Certificates
PU
01/19Sun Pharma to announce third quarter results on January 31, 2022
AQ
01/13Indian Benchmarks Extend Gains on Thursday; Tata Steel Jumps 6%
MT
01/04Indian Indices Extend Gains on Tuesday; NTPC Jumps 6%
MT
2021Sun Pharma receives DCGI approval for Molxvir (Molnupiravir) in India
AQ
2021Indian Indices Close in Red Midweek; Eicher Motors Climbs 3%
MT
2021Sun Pharmaceutical Industries to Set Up Manufacturing Facility in Andhra Pradesh, India
MT
2021Indian Indices Extend Gains on Tuesday; Asian Paints Climbs 3%
MT
2021Indian shares end higher on upbeat global cues; tech, auto stocks jump
RE
2021Sun Pharmaceutical Industries Gets Emergency Use Authorization to Sell Generic Molnupir..
MT
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Financials
Sales 2022 384 B 5 156 M 5 156 M
Net income 2022 70 404 M 946 M 946 M
Net cash 2022 93 095 M 1 251 M 1 251 M
P/E ratio 2022 27,0x
Yield 2022 0,64%
Capitalization 1 940 B 26 109 M 26 085 M
EV / Sales 2022 4,82x
EV / Sales 2023 4,25x
Nbr of Employees 37 000
Free-Float -
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | SUNPHARMA | INE044A01036 | MarketScreener
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Last Close Price 808,75 INR
Average target price 923,70 INR
Spread / Average Target 14,2%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Israel Makov Non-Executive Chairman
Atanu Roy SVP & Chief Information Officer
Davinder Singh Executive Vice President-Global Operations